GRDN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline LSBK Q3 2025 Earnings Steady Profitability Amidst Stable Operations BBAI Q1 2026 Earnings EPS Misses Estimates as Losses Widen DORM Q1 2026 Earnings EPS Misses Estimates Stock Under Pressure SOHOB Q2 2025 Earnings Preferred Stock Reports EPS of 021 Amid Steady Performance